Cargando…

Regulation of tumor immune suppression and cancer cell survival by CXCL1/2 elevation in glioblastoma multiforme

The invasiveness and high immune suppression of glioblastoma multiforme (GBM) produce poor survival of afflicted patients. Unfortunately, in the past decades, no therapeutic approach has remarkably improved the survival time of patients with GBM. Our analysis of the TCGA database and brain tumor tis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Jiemiao, Zhao, Qingnan, Kong, Ling-Yuan, Wang, Jian, Yan, Jun, Xia, Xueqing, Jia, Zhiliang, Heimberger, Amy B., Li, Shulin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for the Advancement of Science 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7840139/ https://www.ncbi.nlm.nih.gov/pubmed/33571109 http://dx.doi.org/10.1126/sciadv.abc2511

Ejemplares similares

FGL2-targeting T cells exhibit antitumor effects on glioblastoma and recruit tumor-specific brain-resident memory T cells
por: Zhao, Qingnan, et al.
Publicado: (2023)

MiR-181 Family Modulates Osteopontin in Glioblastoma Multiforme
por: Marisetty, Anantha, et al.
Publicado: (2020)

A microfluidics-based method for isolation and visualization of cells based on receptor-ligand interactions
por: Dao, Long, et al.
Publicado: (2022)

Survival Analysis of Glioblastoma Multiforme
por: Witthayanuwat, Supapan, et al.
Publicado: (2018)

Tumor-targeted IL-12 combined with tumor resection yields a survival-favorable immune profile
por: Zhao, Qingnan, et al.
Publicado: (2019)

FGL2 promotes tumor progression in the CNS by suppressing CD103(+) dendritic cell differentiation
por: Yan, Jun, et al.
Publicado: (2019)

Author Correction: FGL2 promotes tumor progression in the CNS by suppressing CD103(+) dendritic cell differentiation
por: Yan, Jun, et al.
Publicado: (2019)

Network Signatures of Survival in Glioblastoma Multiforme
por: Patel, Vishal N., et al.
Publicado: (2013)

Immune phenotypes predict survival in patients with glioblastoma multiforme
por: Mostafa, Haouraa, et al.
Publicado: (2016)

Potential Function of Exogenous Vimentin on the Activation of Wnt Signaling Pathway in Cancer Cells
por: Satelli, Arun, et al.
Publicado: (2016)

Induction of NKG2D ligand expression on tumor cells by CD8(+) T cell engagement-mediated activation of nuclear factor-kappa B and p300/CBP-associated factor
por: Hu, Jiemiao, et al.
Publicado: (2019)

Simultaneous impact of atorvastatin and mesenchymal stem cells for glioblastoma multiform suppression in rat glioblastoma multiform model
por: Goodarzi, Arash, et al.
Publicado: (2020)

miR-340 suppresses glioblastoma multiforme
por: Huang, Daquan, et al.
Publicado: (2015)

A genetic survival network for glioblastoma multiforme
por: Lin, Andy, et al.
Publicado: (2011)

Lycorine inhibits glioblastoma multiforme growth through EGFR suppression
por: Shen, Jia, et al.
Publicado: (2018)

Glioblastoma Multiforme
por: Sheehan, Jonas M., et al.
Publicado: (2012)

Immune checkpoint regulator PD-L1 expression on tumor cells by contacting CD11b positive bone marrow derived stromal cells
por: Noh, Hyangsoon, et al.
Publicado: (2015)

Generation of a monoclonal antibody against the glycosylphosphatidylinositol-linked protein Rae-1 using genetically engineered tumor cells
por: Hu, Jiemiao, et al.
Publicado: (2014)

Survival with dacarbazine and fotemustine in newly diagnosed glioblastoma multiforme
por: Fazeny-Dörner, B, et al.
Publicado: (2003)

MRI Manifestions Correlate with Survival of Glioblastoma Multiforme Patients
por: Li, Wen-bin, et al.
Publicado: (2012)

High metallothionein predicts poor survival in glioblastoma multiforme
por: Mehrian-Shai, Ruty, et al.
Publicado: (2015)

Advances in Immunotherapy for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2017)

WSX1 act as a tumor suppressor in hepatocellular carcinoma by downregulating neoplastic PD-L1 expression
por: Wu, Man, et al.
Publicado: (2021)

Suppressing TRAP1 sensitizes glioblastoma multiforme cells to temozolomide
por: Wang, Nan, et al.
Publicado: (2021)

Glioblastoma multiforme – an overview
por: Urbańska, Kaja, et al.
Publicado: (2014)

Incidentalomas to glioblastoma multiforme
por: Sachdev, Bobby, et al.
Publicado: (2014)

Discovery of cell surface vimentin targeting mAb for direct disruption of GBM tumor initiating cells
por: Noh, Hyangsoon, et al.
Publicado: (2016)

Cancer Stem Cells in Glioblastoma Multiforme
por: Bradshaw, Amy, et al.
Publicado: (2016)

Proteogenomic characterization and integrative analysis of glioblastoma multiforme
por: Song, Ying-Chun, et al.
Publicado: (2017)

Molecular Predictors of Long-Term Survival in Glioblastoma Multiforme Patients
por: Lu, Jie, et al.
Publicado: (2016)

Multiparameter MRI Predictors of Long-Term Survival in Glioblastoma Multiforme
por: Stringfield, Olya, et al.
Publicado: (2019)

Potential improvement of survival statistics for glioblastoma multiforme (WHO IV)
por: Goldsmith, Harry S.
Publicado: (2019)

CD8(+)T cell–specific induction of NKG2D receptor by doxorubicin plus interleukin-12 and its contribution to CD8(+)T cell accumulation in tumors
por: Hu, Jiemiao, et al.
Publicado: (2014)

Cancer Stem Cell Hierarchy in Glioblastoma Multiforme
por: Bradshaw, Amy, et al.
Publicado: (2016)

Estimating survival time of patients with glioblastoma multiforme and characterization of the identified microRNA signatures
por: Yerukala Sathipati, Srinivasulu, et al.
Publicado: (2016)

Saponin 1 Induces Apoptosis and Suppresses NF-κB-Mediated Survival Signaling in Glioblastoma Multiforme (GBM)
por: Li, Juan, et al.
Publicado: (2013)

Elevation of CXCL1 indicates poor prognosis and radioresistance by inducing mesenchymal transition in glioblastoma
por: Alafate, Wahafu, et al.
Publicado: (2020)

Tectal plate glioblastoma multiforme
por: Nemer, Michael D., et al.
Publicado: (2011)

Bilateral cystic glioblastoma multiforme
por: Kumar, Sushil, et al.
Publicado: (2013)

Glioblastoma Multiforme Stem Cells
por: Dimov, Irena, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_689sandigqtpd04dfh59hsg9rn